Compare Intiland Development Tbk. (DILD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intiland Development Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intiland Development Tbk. trades at Rp115 (market cap 1.2T, 12.33M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Intiland Development Tbk. is far larger — about 7.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Intiland Development Tbk. is more actively traded (12.33M versus 71K). Which is the better fit depends on your goals.
| DILD | OBAT | |
|---|---|---|
Market Cap | 1.2T | 167.37B |
Volume | 12.33M | 71K |
Lot | 123.31K | 710 |
Turnover | 1.42B | 17.51M |
Average Price | 115.27 | 246.63 |
Value | 1.42B | 17.51M |
Indicative Equilibrium Price | 115 | 246 |
Indicative Equilibrium Volume | 33 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intiland Development Tbk.
PT Intiland Development Tbk formerly Dharmala Intiland, controlled by the Gondokusumo family, was established in 1983 as the property arm of the Dharmala Group. The company is basically a real estate developer with its principal asset being the 240-hectare Grande Family Estate in Surabaya.
Read more on DILD →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
